ISIN | LU0208604644 |
---|---|
Valor Number | 2025172 |
Bloomberg Global ID | BBG000G2DYY1 |
Fund Name | Pictet - Europe Index -P dy EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the fund is to achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 199.09 EUR | 09.09.2025 |
---|---|---|
Previous Price * | 198.93 EUR | 08.09.2025 |
52 Week High * | 201.94 EUR | 22.08.2025 |
52 Week Low * | 167.19 EUR | 09.04.2025 |
NAV * | 199.09 EUR | 09.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,257,111,041 | |
Unit/Share Assets *** | 3,981,669 | |
Trading Information SIX |
YTD Performance | +11.06% |
31.12.2024 - 09.09.2025
31.12.2024 09.09.2025 |
---|---|---|
YTD Performance (in CHF) | +10.31% |
31.12.2024 - 09.09.2025
31.12.2024 09.09.2025 |
1 month | +1.41% |
11.08.2025 - 09.09.2025
11.08.2025 09.09.2025 |
3 months | +0.08% |
09.06.2025 - 09.09.2025
09.06.2025 09.09.2025 |
6 months | +2.94% |
10.03.2025 - 09.09.2025
10.03.2025 09.09.2025 |
1 year | +7.95% |
09.09.2024 - 09.09.2025
09.09.2024 09.09.2025 |
2 years | +20.38% |
11.09.2023 - 09.09.2025
11.09.2023 09.09.2025 |
3 years | +31.14% |
09.09.2022 - 09.09.2025
09.09.2022 09.09.2025 |
5 years | +52.28% |
09.09.2020 - 09.09.2025
09.09.2020 09.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.43% | |
---|---|---|
ASML Holding NV | 2.24% | |
AstraZeneca PLC | 1.89% | |
Nestle SA | 1.87% | |
Roche Holding AG | 1.80% | |
Novartis AG Registered Shares | 1.79% | |
HSBC Holdings PLC | 1.75% | |
Shell PLC | 1.74% | |
Siemens AG | 1.59% | |
Novo Nordisk AS Class B | 1.26% | |
Last data update | 31.07.2025 |
TER *** | 0.45% |
---|---|
TER date *** | 31.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.45% |
Ongoing Charges *** | 0.45% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |